Keywords Vibegron Trade Name: Gemtesa, Obgemsa (FDA approved Dec 28, 2020) Drug Class: Beta-3 Selective agonist Mechanism of Action: Stimulation of beta-3 adrenergic receptors relaxes detrusor smooth muscle during bladder filling, thereby increasing bladder capacity
The most common side effects of GLP-1 injections are gastrointestinal: nausea, vomiting, diarrhea, and constipation
2 AminianA.ZajichekA.TuC.WolskiK
Of 18 SLE patients on GLP-1 medications, only one experienced a mild-to-moderate flare during follow-up
Refrigerate 45 minutes prior to use
And it found something the marketing never mentions: at the higher dose, 30 mL a day for 10 days, there was a signal of harm, with non-fatal serious adverse events nearly tripling, a risk ratio of 2.87 (1.24 to 6.69), across two trials and 1,189 people